MSH's 2003 Annual Report is now available
BOSTON, MA (JUNE 3, 2004) — Hundreds of millions of people worldwide lack access to basic, inexpensive drugs. Because of this gap, millions die every year from treatable diseases such as malaria, tuberculosis, and diarrhea. The devastating impact of the AIDS pandemic can be minimized only with access to antiretroviral drug treatment and medicines to treat complications of AIDS.
Much of the value of a nation's investment in managing life-threatening diseases and reducing disparities in health depends on having the right medicine in the right place at the right time. Training health workers and building and operating hospitals and health services will fail without the key medicines and supplies that can make, and keep, patients well. Therefore, government agencies responsible for health issues must identify the most cost-effective ways to select, procure, distribute, and promote the rational use of drugs, vaccines, and health supplies.
To help address this problem, 30 years ago, Management Sciences for Health (MSH) began its work in the field of pharmaceutical management. MSH has since established itself as a leader in helping policymakers, nongovernmental organizations, donors, and others work together to ensure that high-quality essential drugs are available, affordable, and used rationally.
MSH's 2003 Annual Report highlights this long-standing commitment to improve the management and use of medicines around the world-an issue of major national and international interest. With reliable access to basic medicines, millions of needless deaths can be prevented.